| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.087 | 0.03 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.03 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.083 | 0.05 |